Profile of infections and antimicrobial treatment among burn-injury patients.
Infections are the leading cause of morbidity and mortality among burn-injury patients. Even in the absence of documented infection, antibiotics are often given to burn-injury patients at the beginning of treatment, an empirical measure in response to signs and symptoms of infection. The choice of antimicrobial therapy for these patients should be based on technical criteria, based on laboratory findings, at the risk of further increasing antimicrobial resistance levels.
Rodovia Raposo Tavares, University of Sorocaba, Sorocaba, São Paulo, Brazil.
Delmo
D
Sakabe
Rodovia Raposo Tavares, University of Sorocaba, Sorocaba, São Paulo, Brazil. Electronic address: fernando.fiol@prof.uniso.br.
Fernando de Sá
Fde S
Del Fiol
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002056:Burns / Q000150:complications*; D002648:Child; D004363:Drug Utilization; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017192:Skin Diseases, Bacterial / Q000188:drug therapy* / Q000453:epidemiology*; D055815:Young Adult
D000890:Anti-Infective Agents
Antibiotic use; Antimicrobial resistance